Registry for tracking outcomes of transcatheter aortic valve replacement
Society of Thoracic Surgeons and American College of Cardiology Transcatheter Valve Therapy Registry (STS/ACC TVT Registry).
This study is tracking how well transcatheter aortic valve replacement works for people with severe heart valve problems to help improve patient care and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 16000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The Society of Thoracic Surgeons Academic / other |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Trial ID | NCT01737528 on ClinicalTrials.gov |
What this trial studies
The TVT Registry is a national surveillance system designed to monitor patient safety and real-world outcomes associated with transcatheter aortic valve replacement (TAVR) for patients with severe symptomatic aortic valve stenosis. Participating hospitals submit patient-level data to assess the quality of care and outcomes for those undergoing this innovative procedure. The registry aims to provide periodic reports to healthcare providers to improve care quality and support further research based on collected data.
Who should consider this trial
Good fit: Ideal candidates for this registry are adults aged 18 years or older with severe symptomatic native aortic valve stenosis who are inoperable or at high risk for open aortic valve replacement.
Not a fit: Patients who do not have severe symptomatic aortic valve stenosis or are not considered high risk for surgery may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance the safety and effectiveness of transcatheter aortic valve replacement, ultimately improving patient outcomes.
How similar studies have performed: Other studies utilizing registry-based approaches for monitoring outcomes in cardiac procedures have shown success, indicating that this methodology is both effective and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * 18 years or older
Where this trial is running
Washington D.C., District of Columbia
- American College of Cardiology — Washington D.C., District of Columbia, United States (Recruiting)
Study contacts
- Principal investigator: John D Carroll, MD — American College of Cardiology
- Study coordinator: Joan Michaels
- Email: jmichael@acc.org
- Phone: (202) 375 6309
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.